Clinical Trial Protocol for Yalom Group Therapy in Chinese Women with Depression

Yue Zhou authored a study protocol for a prospective, quasi-experimental clinical trial evaluating stepwise Yalom group therapy. The protocol describes a study of 90 Chinese female patients with depressive disorders, comparing therapy plus standard care against standard care alone. The document was last updated on 2026-05-07 and is shared under a CC-BY-4.0 license.

Use Cases

• Analyzing the study design and methodology for a clinical trial based on the detailed protocol description.
• Reviewing inclusion and exclusion criteria for patient recruitment in depression studies based on the listed criteria.
• Comparing primary and secondary outcome measures for therapy efficacy studies based on the described HAMD-17 and interpersonal difficulty scales.

Strengths

• The protocol is detailed, specifying a sample size of 90 participants and clear inclusion/exclusion criteria.
• Primary and secondary outcomes are explicitly defined, focusing on depressive symptoms, interpersonal difficulties, anxiety, and social functioning.
• The study is registered with a public clinical trial registry (ChiCTR2600116067), enhancing transparency.

Limitations

• The dataset is a 164.5 KB PDF protocol document, not the underlying clinical trial data, which limits direct analysis.
• Column-level documentation for any resulting data is absent; field semantics must be inferred after download.
• The row count for any potential resulting dataset is unknown, which may limit suitability assessment.

Provenance

Source

Yue Zhou via figshare

Collection Method

Described as a prospective, single-center, quasi-experimental study protocol.

Freshness

Last updated 2026-05-07 05:44:05; freshness should be verified.

Geography

Single-center study in China, focusing on Chinese female patients.